IL135904A - Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration - Google Patents
Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regenerationInfo
- Publication number
- IL135904A IL135904A IL13590498A IL13590498A IL135904A IL 135904 A IL135904 A IL 135904A IL 13590498 A IL13590498 A IL 13590498A IL 13590498 A IL13590498 A IL 13590498A IL 135904 A IL135904 A IL 135904A
- Authority
- IL
- Israel
- Prior art keywords
- application
- order
- neural
- substituted aminomethyl
- promote
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19751949A DE19751949A1 (de) | 1997-11-24 | 1997-11-24 | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
PCT/EP1998/007197 WO1999026621A1 (de) | 1997-11-24 | 1998-11-11 | Verwendung von substituierten aminomethyl-chromanen zur verhinderung der neuronalen degeneration und zur förderung der neuronalen regeneration |
Publications (2)
Publication Number | Publication Date |
---|---|
IL135904A0 IL135904A0 (en) | 2001-05-20 |
IL135904A true IL135904A (en) | 2003-07-06 |
Family
ID=7849618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13590498A IL135904A (en) | 1997-11-24 | 1998-11-11 | Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration |
Country Status (30)
Country | Link |
---|---|
US (2) | US6235774B1 (tr) |
EP (1) | EP1051170B1 (tr) |
JP (1) | JP2001523716A (tr) |
KR (1) | KR20010032357A (tr) |
CN (1) | CN1134256C (tr) |
AR (1) | AR016973A1 (tr) |
AT (1) | ATE206615T1 (tr) |
AU (1) | AU745759B2 (tr) |
BG (1) | BG64167B1 (tr) |
CA (1) | CA2311126A1 (tr) |
DE (2) | DE19751949A1 (tr) |
DK (1) | DK1051170T3 (tr) |
ES (1) | ES2164465T3 (tr) |
HN (1) | HN1998000169A (tr) |
HU (1) | HUP0004369A3 (tr) |
IL (1) | IL135904A (tr) |
IS (1) | IS5496A (tr) |
MY (1) | MY118414A (tr) |
NO (1) | NO20002638D0 (tr) |
NZ (1) | NZ504656A (tr) |
PE (1) | PE134999A1 (tr) |
PL (1) | PL340674A1 (tr) |
PT (1) | PT1051170E (tr) |
RU (1) | RU2217140C2 (tr) |
SI (1) | SI1051170T1 (tr) |
SV (1) | SV1998000138A (tr) |
TR (1) | TR200001471T2 (tr) |
TW (1) | TW524690B (tr) |
WO (1) | WO1999026621A1 (tr) |
ZA (1) | ZA9810668B (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19751949A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
US20030207890A1 (en) | 2001-02-23 | 2003-11-06 | Collier Robert J | Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
CA2400637A1 (en) * | 2000-03-17 | 2001-09-27 | Robert J. Collier, Jr. | Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
DE10058119A1 (de) * | 2000-11-22 | 2002-05-23 | Bayer Ag | Pepinotan-Kit |
SE0004455D0 (sv) * | 2000-12-01 | 2000-12-01 | Milos Pekny | Method for neuron regeneration in the central nervous system |
DE10101917A1 (de) * | 2001-01-16 | 2002-07-18 | Bayer Ag | Verwendung von Chromanen |
DK1408964T3 (da) * | 2001-07-26 | 2007-05-21 | Merck Patent Gmbh | Hidtil ukendt anvendelse af 2-5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman og fysiologisk acceptable salte deraf |
ES2272771T3 (es) * | 2001-09-12 | 2007-05-01 | Merck Patent Gmbh | Uso de aminometil cromanos sustituidos en el tratamiento de transtornos extrapirimidales del movimiento. |
DE10155075A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Cyclische Sulfonamide |
ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
DE102004017627A1 (de) * | 2004-04-10 | 2005-10-27 | Bayer Healthcare Ag | Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression |
CN110087687A (zh) | 2016-07-29 | 2019-08-02 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
AU2017301769B2 (en) | 2016-07-29 | 2022-07-28 | Pgi Drug Discovery Llc | Compounds and compositions and uses thereof |
RU2651756C1 (ru) * | 2017-05-10 | 2018-04-23 | Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ | Препарат для предотвращения образования глиальных рубцов |
SG11202000669VA (en) * | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
AU2020236225A1 (en) | 2019-03-14 | 2021-09-16 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300523A (en) | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
FR2662355B1 (fr) | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
DE4135474A1 (de) | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
DE19522088A1 (de) * | 1995-06-19 | 1997-01-02 | Bayer Ag | Benzisothiazolyl-substituierte Aminomethylchromane |
DE19751949A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
-
1997
- 1997-11-24 DE DE19751949A patent/DE19751949A1/de not_active Withdrawn
-
1998
- 1998-10-26 HN HN1998000169A patent/HN1998000169A/es unknown
- 1998-11-11 HU HU0004369A patent/HUP0004369A3/hu unknown
- 1998-11-11 DK DK98961174T patent/DK1051170T3/da active
- 1998-11-11 IL IL13590498A patent/IL135904A/xx active IP Right Grant
- 1998-11-11 RU RU2000116547/14A patent/RU2217140C2/ru not_active IP Right Cessation
- 1998-11-11 PL PL98340674A patent/PL340674A1/xx unknown
- 1998-11-11 KR KR1020007005593A patent/KR20010032357A/ko not_active Application Discontinuation
- 1998-11-11 ES ES98961174T patent/ES2164465T3/es not_active Expired - Lifetime
- 1998-11-11 EP EP98961174A patent/EP1051170B1/de not_active Expired - Lifetime
- 1998-11-11 AU AU16685/99A patent/AU745759B2/en not_active Ceased
- 1998-11-11 NZ NZ504656A patent/NZ504656A/en unknown
- 1998-11-11 US US09/554,971 patent/US6235774B1/en not_active Expired - Fee Related
- 1998-11-11 DE DE59801724T patent/DE59801724D1/de not_active Expired - Fee Related
- 1998-11-11 CN CNB988114453A patent/CN1134256C/zh not_active Expired - Fee Related
- 1998-11-11 TR TR2000/01471T patent/TR200001471T2/tr unknown
- 1998-11-11 PT PT81108222T patent/PT1051170E/pt unknown
- 1998-11-11 CA CA002311126A patent/CA2311126A1/en not_active Abandoned
- 1998-11-11 AT AT98961174T patent/ATE206615T1/de not_active IP Right Cessation
- 1998-11-11 TW TW087118723A patent/TW524690B/zh not_active IP Right Cessation
- 1998-11-11 WO PCT/EP1998/007197 patent/WO1999026621A1/de not_active Application Discontinuation
- 1998-11-11 JP JP2000521823A patent/JP2001523716A/ja not_active Withdrawn
- 1998-11-11 SI SI9830038T patent/SI1051170T1/xx unknown
- 1998-11-19 AR ARP980105881A patent/AR016973A1/es not_active Application Discontinuation
- 1998-11-20 MY MYPI98005285A patent/MY118414A/en unknown
- 1998-11-23 ZA ZA9810668A patent/ZA9810668B/xx unknown
- 1998-11-23 PE PE1998001138A patent/PE134999A1/es not_active Application Discontinuation
- 1998-11-24 SV SV1998000138A patent/SV1998000138A/es unknown
-
2000
- 2000-05-15 IS IS5496A patent/IS5496A/is unknown
- 2000-05-22 BG BG104466A patent/BG64167B1/bg unknown
- 2000-05-23 NO NO20002638A patent/NO20002638D0/no unknown
-
2001
- 2001-03-09 US US09/803,621 patent/US6331561B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135904A0 (en) | Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration | |
PL335194A1 (en) | Arylsulphonamides and their analogues as well as their application in treating neurodegenerative affections | |
PL341355A1 (en) | Hydrocracking process selective in respect to middle fraction of distillate | |
GB2303321B (en) | Improvements in and relating to grinding | |
GB2307937B (en) | Improvements in and relating to security | |
GB9502584D0 (en) | Improvements in and relating to wwarf removal | |
GB9700490D0 (en) | Improvements in and relating to members | |
GB9702355D0 (en) | Improvements in and relating to computers | |
GB2322360B (en) | Improvements in and relating to cartons | |
GB2315081B (en) | Improvements in and relating to hoardings | |
IL118120A0 (en) | Methods of preventing neuron degeneration and promoting neuron regeneration | |
GB9802347D0 (en) | Improvements in and relating to bioremediation | |
GB9707589D0 (en) | Improvements in and relating to treatment | |
GB9718664D0 (en) | Improvements in or relating to capsules | |
GB2298586B (en) | Improvements in and relating to puzzles | |
GB9723767D0 (en) | Improvements in and relating to seperation | |
GB9602806D0 (en) | Improvements in and relating to jewellery | |
GB9725687D0 (en) | Improvements in and relating to bioremediation | |
GB9510301D0 (en) | Improvements in and relating to personal computers | |
GB9707199D0 (en) | Improvements in and relating to turnables | |
GB9704906D0 (en) | Improvements in and relating to hoisery | |
GB9711151D0 (en) | Improvements in and relating to avalves | |
GB9712491D0 (en) | Improvements in and relating to spring manufacture | |
GB9720171D0 (en) | Improvements in and relating to doors | |
GB9708820D0 (en) | Improvements in and relating to brine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |